Aerovate Therapeutics, Inc.
NASDAQ:AVTE
1.98 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0.028 | 0.028 | 0.028 | 0.025 | 0.022 | 0.021 | 0.02 | 0.02 | 0.017 | 0.011 | 0.008 | 0.003 | 0.002 | 0.002 | 0 | 0 | 0 | 0 |
| Brutowinst
| -0.028 | -0.028 | 0.108 | -0.025 | -0.022 | -0.021 | -0.02 | -0.02 | -0.017 | -0.011 | -0.008 | -0.003 | -0.002 | -0.002 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 21.248 | 20.08 | 17.813 | 16.884 | 16.034 | 13.488 | 12.221 | 10.783 | 8.363 | 7.255 | 5.046 | 3.418 | 4.327 | 2.196 | 3.297 | 1.966 | 1.471 | 1.206 |
| Algemene en administratieve kosten
| 4.917 | 4.538 | 4.253 | 4.484 | 4.302 | 4.151 | 3.631 | 3.369 | 3.852 | 3.764 | 3.222 | 2.782 | 1.447 | 0.584 | 0.366 | 0.277 | 0.154 | 0.152 |
| Verkoop- en marketingkosten
| -0.028 | -0.028 | -0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 4.889 | 4.51 | 4.225 | 4.484 | 4.302 | 4.151 | 3.631 | 3.369 | 3.852 | 3.764 | 3.222 | 2.782 | 1.447 | 0.584 | 0.366 | 0.277 | 0.154 | 0.152 |
| Overige kosten
| -0.006 | -0.003 | 0.001 | 0.001 | -0.001 | -0.001 | -0.077 | 0.004 | -0.006 | 0 | 0.001 | 0 | -0.003 | -0.001 | -0.003 | -0.064 | -0.54 | -0.04 |
| Bedrijfskosten
| 26.137 | 24.59 | 22.038 | 21.368 | 20.336 | 17.639 | 15.852 | 14.152 | 12.215 | 11.019 | 8.268 | 6.2 | 5.774 | 2.78 | 3.663 | 2.243 | 1.625 | 1.358 |
| Bedrijfsresultaat
| -26.165 | -24.618 | -22.066 | -21.368 | -20.336 | -17.639 | -15.852 | -14.152 | -12.215 | -11.019 | -8.268 | -6.2 | -5.774 | -2.78 | -3.663 | -2.243 | -1.625 | -1.358 |
| Bedrijfsresultaat ratio
| 0 | 0 | -162.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 1.39 | 1.432 | 1.709 | 1.805 | -0.001 | 1.119 | 0.855 | 0.564 | 0.224 | 0.109 | 0.001 | 0.016 | -0.003 | -0.001 | -0.003 | -0.064 | -0.54 | -0.04 |
| Inkomen voor belasting
| -24.775 | -23.186 | -20.357 | -19.563 | -19.025 | -16.52 | -14.997 | -13.588 | -11.991 | -10.91 | -8.22 | -6.184 | -5.775 | -2.781 | -3.666 | -2.307 | -2.202 | -1.436 |
| Inkomen voor belasting ratio
| 0 | 0 | -149.684 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | -0.015 | 0.056 | -0.025 | -1.312 | -1.119 | 0.025 | -0.564 | -0.224 | -0.109 | 0.003 | 0 | -0.002 | -0.001 | -0.647 | -2.243 | -1.588 | 0.038 |
| Nettowinst
| -24.775 | -23.186 | -20.413 | -19.563 | -19.025 | -15.401 | -15.022 | -13.024 | -11.767 | -10.801 | -8.223 | -6.184 | -5.775 | -2.781 | -3.666 | -2.307 | -2.202 | -1.436 |
| Nettowinstmarge
| 0 | 0 | -150.096 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.86 | -0.83 | -0.74 | -0.71 | -0.76 | -0.62 | -0.61 | -0.53 | -0.48 | -0.44 | -0.34 | -0.26 | -23.76 | -0.13 | -15.08 | -9.49 | -9.06 | -0.32 |
| Verwaterde WPA
| -0.86 | -0.83 | -0.74 | -0.71 | -0.76 | -0.62 | -0.61 | -0.53 | -0.48 | -0.44 | -0.34 | -0.26 | -23.76 | -0.13 | -15.08 | -9.49 | -9.06 | -0.32 |
| EBITDA
| -26.137 | -24.59 | -22.038 | -21.368 | -20.314 | -17.618 | -15.832 | -14.132 | -12.198 | -11.008 | -8.26 | -6.197 | -5.772 | -2.779 | -4.309 | -2.243 | -1.625 | -1.398 |
| EBITDA ratio
| 0 | 0 | -162.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |